
|Articles|December 1, 2012
Statins linked with reduced prostate volume growth
Men taking statin drugs had a modest reduction in prostate growth in a new analysis of a 4-year, large, randomized trial of the dual 5-alpha-reductase inhibitor dutasteride (Avodart) versus placebo for risk reduction of prostate cancer among high-risk men.
Advertisement
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Urology Times
1
Toni Choueiri, MD, reacts to FDA approval of adjuvant belzutifan with pembrolizumab for ccRCC
2
Dean Elterman, MD, highlights efficacy and safety data on the Zenflow Prostatic Spring
3
FDA approves capivasertib plus abiraterone and prednisone for PTEN-deficient mHSPC
4
The UroOnc Minute: Variant Histologies in Bladder Cancer, With Carissa Chu, MD
5











